Tempus AI, Inc. (TEM) - Gross Profit Ratio

Official company branding of Tempus AI, Inc. (TEM)

Tempus AI, Inc (TEM) brings together leading data scientists and oncologists to advance personalized medicine. The gross margin history confirms the effectiveness of this approach, where the 63.50 metric determines this level. Synergy with pharmaceutical behemoths accelerates the creation of AI-driven drugs, while the demand for genomic tests generates a stable cash flow during this active growth phase.

Gross Profitability: Tempus (TEM) for 06/15/2024 - 11/19/2026

Analytical breakdowns and data insights for company tempus.com (TEM)

- price and consensus price forecast:
- market capitalization indicators:
Fundamental valuation:Tempus AI, Inc
Brand item of Tempus AI, Inc

Gross margin reflects the portion of revenue remaining after paying direct production costs, which characterizes the business's pricing resilience. Analyzing the gross margin ratio allows for an assessment of cost management efficiency and the company's ability to pass costs onto customers. This metric measures operational efficiency by determining the volume of resources available to cover administrative expenses. For Tempus AI, Inc (TEM), growth in this indicator confirms the monetization of genomic data scale through licensing and sequencing.

Key competitors

Gross Sales Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Gross Margin|Repligen Inc. - Gross Profitability Margin|Gross Margin RNA|CRSP - Gross Profit Margin|GeneDx - Return on Gross Profit|Gross Profit Rate RARE|Beam Tx - Gross Margin|SRPT - Gross Margin|TWST (Twist Bio) - Return on Gross Profit|Gross Return on Sales TXG|Return on Gross Profit NTLA|Stoke Therapeutics Inc (STOK) - Return on Sales by Gross Profit|Gross Margin BLFS|Gross Profitability WVE (Wave Life Sciences Corp)|Gross Profitability Maze Therapeutics MAZE|Gross Profit Rate SION|PRME - Gross Profitability|Return on Sales by Gross Profit Taysha TSHA|QURE: Gross Margin|Return on Gross Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Gross Margin|solidbio.com (SLDB) - Return on Sales by Gross Profit|Gross Profitability Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Gross Return on Sales|Benitec Biopharma - Return on Gross Profit|DSGN: Gross Return on Sales|RCKT: Return on Gross Profit|FDMT - Gross Margin|LXEO: Gross Margin|Korro Bio Inc. - Gross Profit Rate|EDIT (editasmedicine.com) - Gross Margin|Gross Profitability SLN|Gross Profitability ProQR Therapeutics NV (PRQR)|Codexis - Gross Return on Sales|Gross Profitability Sangamo SGMO|NAUT: Gross Return on Sales|MGX: Return on Gross Profit|Gross Profit Margin Precision BioSciences|GBIO (generationbio.com) - Return on Gross Profit|Gross Profit Margin boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Gross Margin|Gross Return on Sales IMNN (Imunon, Inc.)|Gross Margin PHIO|MBIO - Gross Profit Margin|Gross Margin RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Gross Profit Margin|Applied DNA - Gross Margin|Gross Profit Margin Bluebird Bio|ImmunoPrecise (IPA) - Gross Profitability|Gross Profitability Margin OMGA (Omega)|Gross Profitability Singular Genomics Systems|Gross Profit Margin regulusrx.com RGLS|Gross Profitability Syros Pharmaceuticals Inc. (SYRS)|Return on Sales by Gross Profit Codex DNA|Gross Profitability TRACON TCON|Unity Biotechnology, Inc - Gross Profitability